HCG Diet for Cleansing and Fast Weight Loss

The Benefits of PEPTIDE AOD-9604 in SYENRGYrx WEIGHT LOSS FORMULATION

July 26, 2021 By , , , , , , , ,

Peptide AOD 9604 for Weight Loss

HCG DIET PORTLANDIn recent years, peptides have come to the market and some have been very effective!  One of my favorites for weight loss is the peptide AOD 9604.  This peptide is a modified form of amino acids 176-191 that was originally used as an anti-obesity drug.  This peptide can be injected or taken orally to potentially stimulate the pituitary gland, which in turn can potentially speed up metabolism and burn body fat. In our patient population, we have seen steady weight loss when our specific SYNERGYrx weight loss formulation and program is taken along with following out SYNERGYrx weight loss plan.

 

How does AOD-9604 work in the SYNERGYrx Formulation for Weight Loss

The way Peptide AOD 9604 works is thought to be by:

  • Stimulating lipolysis, or the breakdown of fats and lipids via the hydrolyzation of triglycerides into glycerol and fatty acids.
  • Inhibiting lipogenesis, the metabolic process that forms fat (even from nonfat foods), increasing the amount of triglycerides in the body.

The amino acids contained in AOD 9604 are the same as those found in a naturally occurring hormone associated with growth. These are involved in fat reduction, as a Monash University study discovered. When administered alone or in the SYNERGYrx  formulation, the peptide does not seem to affect growth or insulin resistance.  Therefore, it does not have any adverse effects on human growth or on blood sugar levels like the Human Growth Hormone molecule can have.

 

Other Benefits of AOD-9604 in the SYNERGYrx Formulation

Researchers have also discovered the benefits of AOD 9604 aren’t limited to fat loss. It also contains various other regenerative properties that may benefit people with:

  • Osteoarthritis
  • Osteoporosis
  • Hypercholesterolemia
  • Worn cartilage
  • Bone damage
Tags: , , , , , , , , , , , , , , , ,

Categories: , , , , , , , ,